Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II)

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 151; no. 2; p. AB195
Main Authors Szefler, Stanley, Corren, Jonathan, Silverberg, Jonathan, Okragly, Angela, Sun, Zhe, Natalie, Chitra, Zitnik, Ralph, Siu, Kimberly, Blauvelt, Andrew
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2023
Online AccessGet full text

Cover

More Information
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2022.12.609